India's Max Healthcare gains after Jefferies says 'it has significant room for growth'

Max Healthcare Institute

12/06/2025 07:47

** Shares of Max Healthcare Institute MAXE.NS up 2.4% to 1215.8 rupees

** Jefferies maintains "buy" rating for the hospital operator, with PT at 1,400 rupees, ~15% higher than current price

** Phase of aggressive capacity addition has begun for MAXE, and there is significant room for growth in newly acquired units, brokerage says

** MAXE expected to increase bed capacity by ~75% to 9,000 beds in next 3-4 years, co had said in an exchange filing on May 31

** Jefferies expects over 20% EBITDA growth during over the next 2 years for MAXE, says co "remains among the fastest-growing large hospital franchises"

** Stock trading above its 200-day simple moving avgs since March, indicating bullish sentiment

** Avg rating of 20 analysts is "buy", median PT 1,250 rupees, ~3% higher than current price - data compiled by LSEG

** MAXE up ~7% YTD, while peers Fortis Healthcare FOHE.NS up 6%, Apollo Hospitals APLH.NS down 4%

 (Reporting by Anuran Sadhu in Bengaluru)

 ((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))